TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Other Operating Assets of $2.04 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-10-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2021-10-29
- TRAVERE THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2021-09-30 was $821.00K, a 95.35% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2021-06-30 was $498.00K, a 95.11% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2021-03-31 was $726.00K.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2020-09-30 was $17.67M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|---|
| 2021-09-30 | $821.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $1.32M derived: sum of 2 quarters · filed 2021-10-29 | $2.04M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $1.22M 10-Q · filed 2021-07-29 | ||
| 2021-03-31 | $726.00K 10-Q · filed 2021-05-06 | |||
| 2020-09-30 | $17.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $27.85M derived: sum of 2 quarters · filed 2021-10-29 | $20.18M 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $10.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $2.51M 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | -$7.67M 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | -$472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.00K derived: sum of 2 quarters · filed 2020-11-05 | $9.63M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $476.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $10.10M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $9.63M 10-Q · filed 2020-05-11 | $9.32M 10-Q · filed 2019-05-07 | ||
| 2018-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $2.60M derived: sum of 2 quarters · filed 2019-10-30 | $2.18M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | -$216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$637.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$421.00K 10-Q · filed 2019-05-07 | |||
| 2017-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $2.80M derived: sum of 2 quarters · filed 2018-11-01 | $3.75M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | -$934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $12.00K 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $946.00K 10-Q · filed 2018-07-06 | |||
| 2016-09-30 | -$260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $937.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $1.20M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |